- Pharmacological properties and derivatives of shikonin—A review in recent years
Chuanjie Guo et al, 2019, Pharmacological Research CrossRef - Shikonin inhibits cancer cell cycling by targeting Cdc25s
Shoude Zhang et al, 2019, BMC Cancer CrossRef - Shikonin derivatives for cancer prevention and therapy
Joelle C. Boulos et al, 2019, Cancer Letters CrossRef - JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
Haidée Aranda-Tavío et al, 2021, Biomedicine & Pharmacotherapy CrossRef - Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
Fangfang Wang et al, 2020, Frontiers in Pharmacology CrossRef - Synthesis, biological function and evaluation of Shikonin in cancer therapy
Fangfang Wang et al, 2019, Fitoterapia CrossRef - Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes
Birgit Lohberger et al, 2022, International Journal of Molecular Sciences CrossRef - Shikonin Derivatives from Onsoma visianii Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity
Zeljko Todorovic et al, 2021, Nutrients CrossRef - The anti-leukemia activity and mechanisms of shikonin: a mini review
Han Dong et al, 2023, Frontiers in Pharmacology CrossRef - Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways
Hao Wang et al, 2019, Molecular Medicine Reports CrossRef - Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms
Yimeng Guo et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Dexmedetomidine Alleviates Lipopolysaccharide-Induced Hippocampal Neuronal Apoptosis via Inhibiting the p38 MAPK/c-Myc/CLIC4 Signaling Pathway in Rats
Yongping Chen et al, 2021, Molecular Neurobiology CrossRef - Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling
Ziyan Xu et al, 2022, Oncology Letters CrossRef - Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
Birgit Lohberger et al, 2022, BMC Cancer CrossRef - Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways
József Király et al, 2023, Molecules CrossRef - MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Ka Iong Chan et al, 2024, Aging and disease CrossRef - Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells
Ming-Feng Tsai et al, 2021, Antioxidants CrossRef - In vitro mass production, chemical modification, and cytotoxicity of shikonin derivatives on breast cancer cells
Melike Tepe et al, 2023, Industrial Crops and Products CrossRef - Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo et al, 2019, Chinese Medicine CrossRef - Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years
Shengjun Ma et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef